New combo therapy targets tough liver cancer cases
Disease control
Recruiting now
This study is for people with liver cancer that has spread into the main vein of the liver (portal vein tumor thrombus) and can still be removed by surgery. The goal is to see if giving a combination of radiation, an immunotherapy drug (camrelizumab), and a targeted therapy pill …
Phase: PHASE2 • Sponsor: Yongyi Zeng • Aim: Disease control
Last updated May 17, 2026 02:14 UTC